Mahasti Saghatchian Curriculum Vitae and Publications - OECI

English Peer reviewed Publications:
Serfass L, Van Herpen C, Saghatchian M
Cancer control in Africa
Eur J Cancer .2007 Jul ; (10):1493-5
Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang
Y, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F,
Piccart MJ, Buyse M, Sotiriou C; TRANSBIG Consortium
Strong time-dependency of the 76-gene prognostic signature for node-negative breast cancer
patients in the TRANSBIG multicentrer independent validation series.
Clinical Cancer Research, 2007 Jun 1; 13 (11):3207-14
Ach RA, Floore A, Curry B, Lazar V, Glas AM, Pover R, Tsalenko A, Ripoche H, Cardoso F,
d’Assignies MS, Laurakay Bruhn, and Laura J. Van ’t Veer
Robust Interlaboratory Reproducibility of a Gene Expression Signature Measurement
Consistent with the Needs of a New Generation of Diagnostic Tools.
BMC Genomics, 2007 Jun 7;8:148.
Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas A, Saghatchian M, Bergh J, Lidereau R,
Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C,
Cardoso F, Piccart M; TRANSBIG consortium.
Validation and clinical utility of a 70-gene prognostic signature for woman with node negative
breast cancer.
J Natl Cancer Inst, 2006 Sep 6;98(17):1183-92
McCarthy M, Poses RM, Saghatchian M; de Pouvourville G, Tursz T, Gray A
Cancer funding throughout the world.
Lancet Oncol. 2004 Jul; 5(7) 453-7
Saghatchian M, Guepratte S, Hacene K, Neumann R, Floiras JL, Pichon MF.
Serum HER-2 extracellular domain: relationship with clinicobiological presentation and
prognostic value before and after primary treatment in 701 breast cancer patients.
Int J Biol Markers. 2004 Jan-Ma; 19(1): 14-22.
Meunier F, Dubois N, Negrouk A, Rea LA, Saghatchian M, Tursz T, SUlivan R, Law K, Tiner R
Throwing a wrench in the works?
Lancet Oncol. 2003 Dec; 4(12): 717-9
Culine S, Kramar A, Saghatchian M. Bugat R; Lesimple T, Lortholary A, Merrouche Y,
Laplanche A, Fizazi K, French Study Group on Carcinomas of Unknown Primary.
Development and validation of a prognostic model to predict the length of survival in patients
with carcinomas of an unknown primary site.
J Clin Oncol. 2002 Dec 15; 20(24): 4679-83.
Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T, Theodore C.
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological
differentiation – results of a prospective study.
Ann Oncol. 2001 Apr; 12(4): 535-40.
Sharshar T, Auriant I, Dorandeu A, Saghatchian M, Belec L, Benyahia B, Mabro M, Raphael JC,
Gajdos P, Delattre JY, Gray F.
Association of herpes simplex virus encephalitis and paraneoplastic encephalitis – a clinicopathological
study.
Ann Pathol. 2000 May; 20(3): 249-52.